查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713601

2025年代謝生物標記檢測全球市場報告

Metabolic Biomarker Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年代謝生物標記檢測市場規模將強勁成長。到 2029 年，這一數字將成長至 42 億美元，複合年成長率為 8.3%。預測期內的成長歸因於對精準醫療的日益關注、個性化營養和健康計劃的成長、METABOLIC INC.研究資金的增加、患者意識和教育的不斷提高以及METABOLIC INC.症候群和相關疾病患病率的上升。預測期內的關鍵趨勢包括高通量篩檢技術的進步、人工智慧的整合、用於生物標記分析的機器學習的整合、行動醫療（行動醫療）技術的進步以及用於遠端生物標記測試的遠端醫療解決方案的擴展。

糖尿病盛行率的不斷上升預計將推動代謝生物標記檢測市場的成長。糖尿病是一種慢性疾病，由於身體無法產生或正確利用胰島素，導致血糖值升高。糖尿病病例的增加受到不良飲食習慣的影響，尤其是大量食用加工食品和含糖飲料，以及久坐不動、很少運動的生活方式。此外，年齡較大和家族病史也會增加患病風險，顯示有遺傳傾向。代謝生物標記檢測透過提供分子層面上代謝功能和異常的詳細見解，有助於診斷、監測和管理糖尿病等代謝疾病。例如，英國非營利組織英國糖尿病協會於2024年5月報告稱，英國目前有430萬人被診斷患有糖尿病，2022年較2021年增加148,951例。此外，英國有超過240萬人面臨第2型糖尿病的高風險。因此，糖尿病盛行率的不斷上升預計將推動代謝生物標記檢測市場的成長。

代謝生物標記檢測市場的主要企業正專注於自我監測生物穿戴裝置等技術進步，以使用戶能夠持續追蹤和管理他們的營養和健康指標。這些生物穿戴裝置將以非侵入方式即時監測葡萄糖等關鍵代謝標記物，以支援個人化健康管理並最佳化飲食和運動表現。例如，2022年1月，美國醫療設備公司雅培實驗室推出了Lingo生物穿戴裝置。該設備設計為佩戴在上臂上，最長可使用兩週，可讓使用者監測血糖、酮和乳酸水平，從而持續了解自己的代謝健康狀況。該設備利用雅培的 FreeStyle Libre 技術，旨在改善整體健康和運動表現，而不是作為醫療診斷工具。該產品計劃首先在歐洲以 Lingo Keto 品牌推出，並將直接向消費者供應，無需處方箋。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球代謝生物標記檢測PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球代謝生物標記檢測市場：成長率分析
  • 全球代謝生物標記檢測市場表現：規模與成長，2019-2024
  • 全球代謝生物標記檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球代謝生物標記檢測總目標市場（TAM）

第6章市場區隔

  • 全球代謝生物標記檢測市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 分離技術
  • 檢測技術
  • 其他類型
  • 全球代謝生物標記檢測市場：按適應症、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 心血管疾病
  • 神經系統疾病
  • 先天性代謝缺陷
  • 其他適應症
  • 全球代謝生物標記檢測市場的應用、效能和預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 藥物評價
  • 營養基因體學
  • 毒性測試
  • 個人化醫療
  • 功能基因體學
  • 其他用途
  • 全球代謝生物標記檢測市場（依最終用戶、績效及預測）2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 診斷工具公司
  • 醫療保健資訊科技（IT）
  • 臨床實驗室
  • 全球代謝生物標記檢測市場按分離技術類型、性能和預測進行細分，2019-2024 年、2024-2029 年、2034 年
  • 層析法
  • 毛細管電泳
  • 質譜法（MS）
  • 液-液萃取
  • 固相萃取
  • 全球代謝生物標記檢測市場，按檢測技術、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 西方印漬術
  • 基於螢光的檢測
  • 電化學檢測
  • 核磁共振（NMR）
  • 免疫檢測
  • 全球代謝生物標記檢測市場及其他細分市場，依類型、實際規模及預測，2019-2024 年、2024-2029 年、2034 年
  • 基因生物標記檢測
  • 蛋白質生物標記檢測
  • 代謝體學學分析
  • 光譜技術
  • 微陣列技術

第7章 區域和國家分析

  • 全球代謝生物標記檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球代謝生物標記檢測市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 代謝生物標記檢測市場：競爭格局
  • 代謝生物標記檢測市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • LECO Corporation
  • Shimadzu Corporation
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • SCIEX
  • Promega Corporation
  • Cayman Chemical Company
  • Metabolon Inc.
  • Biocrates Life Sciences AG
  • Human Metabolome Technologies Inc.
  • KineMed Inc.
  • Evosep Biosystems A/S
  • Creative Proteomics Inc.
  • Lipotype GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年代謝生物標記檢測市場：提供新機會的國家
  • 2029年代謝生物標記檢測市場：細分市場帶來新機會
  • 2029年代謝生物標記檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33503

Metabolic biomarker testing involves analyzing specific molecules in biological samples, such as blood or urine, to evaluate metabolic processes and identify imbalances or dysfunctions. This testing is crucial for diagnosing metabolic disorders, monitoring health conditions, and developing personalized treatment strategies.

The primary types of metabolic biomarker testing include separation techniques, detection techniques, and other methods. Separation techniques utilize physical or chemical processes to isolate specific metabolites from biological samples based on properties such as size, charge, or affinity. This process aids in purifying and accurately identifying metabolic biomarkers. Indications for testing cover areas such as cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and more. Applications include drug assessment, nutrigenomics, toxicology testing, personalized medicine, and functional genomics. End users of metabolic biomarker testing include pharmaceutical and biotech companies, diagnostic tool companies, healthcare IT providers, and clinical laboratories.

The metabolic biomarker testing market research report is one of a series of new reports from the business research company that provides metabolic biomarker testing market statistics, including metabolic biomarker testing industry global market size, regional shares, competitors with an metabolic biomarker testing market share, detailed metabolic biomarker testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic biomarker testing industry. This metabolic biomarker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolic biomarker testing market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of metabolic disorders, rising awareness about early disease detection, growing demand for personalized medicine, increasing prevalence of obesity and diabetes, and growing adoption of preventive healthcare measures.

The metabolic biomarker testing market size is expected to see strong growth in the next few years. It will grow to $4.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on precision medicine, growth in personalized nutrition and wellness programs, increased funding for metabolic research, growing patient awareness and education, and rising prevalence of metabolic syndrome and related conditions. Major trends in the forecast period include advancements in high-throughput screening technologies, integration of artificial intelligence, integration of machine learning for biomarker analysis, advances in mobile health (mHealth) technologies, and expansion of telemedicine solutions for remote biomarker testing.

The increasing incidence of diabetes is expected to drive the growth of the metabolic biomarker testing market. Diabetes is a chronic condition marked by elevated blood glucose levels due to the body's inability to produce or properly use insulin. The rise in diabetes cases is influenced by poor dietary habits, particularly high consumption of processed foods and sugary drinks, along with sedentary lifestyles with minimal physical activity. Additionally, aging populations and family history of diabetes contribute to increased risk, indicating a genetic predisposition. Metabolic biomarker testing aids in diagnosing, monitoring, and managing metabolic diseases such as diabetes by providing detailed insights into metabolic functions and abnormalities at a molecular level. For example, in May 2024, the British Diabetic Association, a U.K.-based non-profit organization, reported that 4.3 million individuals in the UK are currently diagnosed with diabetes, with an increase of 148,951 cases in 2022 compared to 2021. Furthermore, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Thus, the rising incidence of diabetes is set to propel the growth of the metabolic biomarker testing market.

Major companies in the metabolic biomarker testing market are focusing on technological advancements, such as biowearables for self-monitoring, to enable users to continuously track and manage their nutritional and health indicators. These biowearables provide real-time, non-invasive monitoring of key metabolic markers such as glucose, supporting personalized health management and optimizing diet and athletic performance. For example, in January 2022, Abbott Laboratories, a US-based medical device company, introduced the Lingo biowearable. Designed to be worn on the upper arm for up to two weeks, it allows users to monitor glucose, ketone, and lactate levels, offering continuous insights into metabolic health. Utilizing technology from Abbott's FreeStyle Libre, the device aims to enhance general wellness and athletic performance rather than serving as a medical diagnostic tool. The initial launch was planned for Europe under the Lingo Keto brand, making it available directly to consumers without a prescription.

In June 2024, Lifesum AB, a Sweden-based provider of a healthy eating and wellness platform, acquired Lykon GmbH for an undisclosed amount. This acquisition is intended to integrate Lykon's biomarker testing into Lifesum's platform, enhancing the ability to offer personalized health insights, expanding wellness services, and bolstering Lifesum's position in the advanced wellness market. Lykon GmbH, based in Germany, specializes in personalized metabolic and nutritional testing.

Major companies operating in the metabolic biomarker testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., bioMerieux S.A., LECO Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, SCIEX, Promega Corporation, Cayman Chemical Company, Metabolon Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., KineMed Inc., Evosep Biosystems A/S, Creative Proteomics Inc., Lipotype GmbH, Metabolomic Diagnostics Ltd, Stemina Biomarker Discovery Inc., Chenomx Inc., GlycoPath Pty Ltd

North America was the largest region in the metabolic biomarker testing market in 2024. The regions covered in the metabolic biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metabolic biomarker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metabolic biomarker testing market consists of revenues earned by entities by providing services such as laboratory testing, analysis of blood, urine, and other biological samples, and personalized health assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic biomarker testing market also includes sales of diagnostic kits, assay reagents, and testing equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metabolic Biomarker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metabolic biomarker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metabolic biomarker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metabolic biomarker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Separation Techniques; Detection Techniques; Other Types
  • 2) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors Of Metabolism; Other Indications
  • 3) By Application: Drug Assessment; Nutrigenomics; Toxicology Testing; Personalized Medicine; Functional Genomics; Other Applications
  • 4) By End User: Pharma And Biotech Companies; Diagnostic Tool Companies; Healthcare Information Technology (IT); Clinical Laboratories
  • Subsegments:
  • 1) By Separation Techniques: Chromatography; Capillary Electrophoresis; Mass Spectrometry (MS); Liquid-Liquid Extraction; Solid-Phase Extraction
  • 2) By Detection Techniques: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Fluorescence-Based Detection; Electrochemical Detection; Nuclear Magnetic Resonance (NMR); Immunoassays
  • 3) By Other Types: Genetic Biomarker Testing; Protein Biomarker Testing; Metabolomics Profiling; Spectroscopy Techniques; Microarray Technology
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; bioMerieux S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metabolic Biomarker Testing Market Characteristics

3. Metabolic Biomarker Testing Market Trends And Strategies

4. Metabolic Biomarker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metabolic Biomarker Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Metabolic Biomarker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Metabolic Biomarker Testing Market Growth Rate Analysis
  • 5.4. Global Metabolic Biomarker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Metabolic Biomarker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Metabolic Biomarker Testing Total Addressable Market (TAM)

6. Metabolic Biomarker Testing Market Segmentation

  • 6.1. Global Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Separation Techniques
  • Detection Techniques
  • Other Types
  • 6.2. Global Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Cardiovascular Diorders
  • Neurological Disorders
  • Inborn Errors Of Metabolism
  • Other Indications
  • 6.3. Global Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Assessment
  • Nutrigenomics
  • Toxicology Testing
  • Personalized Medicine
  • Functional Genomics
  • Other Applications
  • 6.4. Global Metabolic Biomarker Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Biotech Companies
  • Diagnostic Tool Companies
  • Healthcare Information Technology (IT)
  • Clinical Laboratories
  • 6.5. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Separation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chromatography
  • Capillary Electrophoresis
  • Mass Spectrometry (MS)
  • Liquid-Liquid Extraction
  • Solid-Phase Extraction
  • 6.6. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Detection Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blotting
  • Fluorescence-Based Detection
  • Electrochemical Detection
  • Nuclear Magnetic Resonance (NMR)
  • Immunoassays
  • 6.7. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Biomarker Testing
  • Protein Biomarker Testing
  • Metabolomics Profiling
  • Spectroscopy Techniques
  • Microarray Technology

7. Metabolic Biomarker Testing Market Regional And Country Analysis

  • 7.1. Global Metabolic Biomarker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Metabolic Biomarker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metabolic Biomarker Testing Market

  • 8.1. Asia-Pacific Metabolic Biomarker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metabolic Biomarker Testing Market

  • 9.1. China Metabolic Biomarker Testing Market Overview
  • 9.2. China Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metabolic Biomarker Testing Market

  • 10.1. India Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metabolic Biomarker Testing Market

  • 11.1. Japan Metabolic Biomarker Testing Market Overview
  • 11.2. Japan Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metabolic Biomarker Testing Market

  • 12.1. Australia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metabolic Biomarker Testing Market

  • 13.1. Indonesia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metabolic Biomarker Testing Market

  • 14.1. South Korea Metabolic Biomarker Testing Market Overview
  • 14.2. South Korea Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metabolic Biomarker Testing Market

  • 15.1. Western Europe Metabolic Biomarker Testing Market Overview
  • 15.2. Western Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metabolic Biomarker Testing Market

  • 16.1. UK Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metabolic Biomarker Testing Market

  • 17.1. Germany Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metabolic Biomarker Testing Market

  • 18.1. France Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metabolic Biomarker Testing Market

  • 19.1. Italy Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metabolic Biomarker Testing Market

  • 20.1. Spain Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metabolic Biomarker Testing Market

  • 21.1. Eastern Europe Metabolic Biomarker Testing Market Overview
  • 21.2. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metabolic Biomarker Testing Market

  • 22.1. Russia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metabolic Biomarker Testing Market

  • 23.1. North America Metabolic Biomarker Testing Market Overview
  • 23.2. North America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metabolic Biomarker Testing Market

  • 24.1. USA Metabolic Biomarker Testing Market Overview
  • 24.2. USA Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metabolic Biomarker Testing Market

  • 25.1. Canada Metabolic Biomarker Testing Market Overview
  • 25.2. Canada Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metabolic Biomarker Testing Market

  • 26.1. South America Metabolic Biomarker Testing Market Overview
  • 26.2. South America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metabolic Biomarker Testing Market

  • 27.1. Brazil Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metabolic Biomarker Testing Market

  • 28.1. Middle East Metabolic Biomarker Testing Market Overview
  • 28.2. Middle East Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metabolic Biomarker Testing Market

  • 29.1. Africa Metabolic Biomarker Testing Market Overview
  • 29.2. Africa Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metabolic Biomarker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Metabolic Biomarker Testing Market Competitive Landscape
  • 30.2. Metabolic Biomarker Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Metabolic Biomarker Testing Market Other Major And Innovative Companies

  • 31.1. LECO Corporation
  • 31.2. Shimadzu Corporation
  • 31.3. Waters Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Bruker Corporation
  • 31.6. SCIEX
  • 31.7. Promega Corporation
  • 31.8. Cayman Chemical Company
  • 31.9. Metabolon Inc.
  • 31.10. Biocrates Life Sciences AG
  • 31.11. Human Metabolome Technologies Inc.
  • 31.12. KineMed Inc.
  • 31.13. Evosep Biosystems A/S
  • 31.14. Creative Proteomics Inc.
  • 31.15. Lipotype GmbH

32. Global Metabolic Biomarker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metabolic Biomarker Testing Market

34. Recent Developments In The Metabolic Biomarker Testing Market

35. Metabolic Biomarker Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Metabolic Biomarker Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Metabolic Biomarker Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Metabolic Biomarker Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33503_Metabolic_Biomarker_Testing_GMR_2025